CA2013770A1 - Utilisation de liposomes pour la liberation d'agents therapeutiques dans les plaies, les coupures et les abrasions - Google Patents

Utilisation de liposomes pour la liberation d'agents therapeutiques dans les plaies, les coupures et les abrasions

Info

Publication number
CA2013770A1
CA2013770A1 CA002013770A CA2013770A CA2013770A1 CA 2013770 A1 CA2013770 A1 CA 2013770A1 CA 002013770 A CA002013770 A CA 002013770A CA 2013770 A CA2013770 A CA 2013770A CA 2013770 A1 CA2013770 A1 CA 2013770A1
Authority
CA
Canada
Prior art keywords
liposomes
mol
diameter
tho
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002013770A
Other languages
English (en)
Inventor
Jack M. Shaw
Diana M. Cordova
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2013770A1 publication Critical patent/CA2013770A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002013770A 1989-04-04 1990-04-03 Utilisation de liposomes pour la liberation d'agents therapeutiques dans les plaies, les coupures et les abrasions Abandoned CA2013770A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33316489A 1989-04-04 1989-04-04
US333,164 1989-04-04

Publications (1)

Publication Number Publication Date
CA2013770A1 true CA2013770A1 (fr) 1990-10-04

Family

ID=23301595

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002013770A Abandoned CA2013770A1 (fr) 1989-04-04 1990-04-03 Utilisation de liposomes pour la liberation d'agents therapeutiques dans les plaies, les coupures et les abrasions

Country Status (8)

Country Link
EP (1) EP0465588A4 (fr)
JP (1) JPH04505319A (fr)
KR (1) KR920700691A (fr)
AU (1) AU633078B2 (fr)
CA (1) CA2013770A1 (fr)
IL (1) IL93996A0 (fr)
WO (1) WO1990011781A1 (fr)
ZA (1) ZA902593B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012808A1 (fr) * 1990-02-22 1991-09-05 Macnaught Pty Limited Larmes artificielles
IT1240683B (it) * 1990-04-26 1993-12-17 Zambon Spa Composizione farmaceutica contenente egf
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
DE69730476T2 (de) * 1996-04-19 2005-11-17 Tsubota, Kazuo, Funabashi Albumin als aktiver Bestandteil zur Behandlung von Bindehaut- und Hornhautverletzungen und von trockenen Augen
EP0982025A1 (fr) * 1998-08-28 2000-03-01 Wilhelm Prof. Dr. Stoffel Larmes artificielles
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
ATE340561T1 (de) 1999-05-27 2006-10-15 Euro Celtique Sa Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
GB9919131D0 (en) * 1999-08-14 1999-10-13 Depuy Int Ltd Joint lubrication
WO2002074281A1 (fr) * 2001-03-15 2002-09-26 Novartis Ag Compositions ophtalmiques et leur utilisation
KR100915741B1 (ko) * 2001-06-15 2009-09-04 코너스톤 파마슈티칼스 표적 조직 및 세포를 치료하기에 유용한 나노입자를함유하는 약제학적 및 진단학적 조성물
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
US20050058767A1 (en) * 2001-09-18 2005-03-17 Bolton Anthony E Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
HK1077740A1 (en) 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
CA2368656A1 (fr) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Appariement recepteur-ligand pour produire une reeaction anti-inflammatoire
AU2003201569B2 (en) * 2002-01-21 2008-09-11 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
EP1549293A1 (fr) * 2002-09-16 2005-07-06 Vasogen Ireland Limited Acceleration du retablissement suite a des traumas
AU2003275842A1 (en) * 2002-10-25 2004-05-13 Vasogen Ireland Limited Cyclooxygenase regulation with pg liposomes
AU2003275850A1 (en) * 2002-10-25 2004-05-13 Vasogen Ireland Limited Cyclooxygenase regulation with ps liposomes
WO2004082688A1 (fr) * 2003-03-20 2004-09-30 Vasogen Ireland Limited Agonistes et antagonistes de recepteur de phosphatidylglycerol (pg)
JP4669665B2 (ja) * 2004-04-12 2011-04-13 正彦 阿部 細胞毒性のないポリカチオン修飾リポソームおよびその製造方法
US8808715B1 (en) * 2004-11-23 2014-08-19 Georgia Regents Research Institute, Inc Methods and compositions for modulating keratinocyte function
CA2622475A1 (fr) * 2005-09-26 2007-04-05 Vasogen Ireland Limited Traitement d'inflammations et d'anomalies vasculaires de l'oeil
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
ES2284398B2 (es) * 2006-04-27 2008-12-16 Universidad Complutense De Madrid Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
JP5514098B2 (ja) 2008-02-29 2014-06-04 公益財団法人名古屋産業科学研究所 後眼部到達用リポソーム及び後眼部疾患用医薬組成物
CN102046151A (zh) * 2008-03-26 2011-05-04 牛津大学 靶向内质网的脂质体
EP2123258A1 (fr) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes pour l'administration de médicaments
KR20120059447A (ko) 2009-03-27 2012-06-08 더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 콜레스테롤 수준 저하 리포좀
CN109922794B (zh) * 2016-08-18 2022-11-04 特洛伊.布雷莫 使用脂质体构建体将尿素递送至黄斑和视网膜的细胞

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540381B1 (fr) * 1983-02-08 1986-05-30 Dior Sa Parfums Christian Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
EP0316345A1 (fr) * 1986-07-28 1989-05-24 Liposome Technology, Inc. Liposomes a retention amelioree sur du tissu muqueux
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method

Also Published As

Publication number Publication date
WO1990011781A1 (fr) 1990-10-18
KR920700691A (ko) 1992-08-10
EP0465588A1 (fr) 1992-01-15
JPH04505319A (ja) 1992-09-17
AU633078B2 (en) 1993-01-21
ZA902593B (en) 1991-01-30
AU5429790A (en) 1990-11-05
IL93996A0 (en) 1991-01-31
EP0465588A4 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
CA2013770A1 (fr) Utilisation de liposomes pour la liberation d'agents therapeutiques dans les plaies, les coupures et les abrasions
US4839175A (en) Liposomes with enhanced retention on mucosal tissue
US4804539A (en) Ophthalmic liposomes
KR100617921B1 (ko) 리포솜 조성물 및 퀴놀론의 투여 방법
DE69207603T2 (de) Zusammensetzung und verfahren zur behandlung von zystischer fibrose
EP0316345A1 (fr) Liposomes a retention amelioree sur du tissu muqueux
US6680068B2 (en) Drug delivery formulations and targeting
CA2743959C (fr) Composition liposomale pour administration amelioree par convection vers le systeme nerveux central
US8110217B2 (en) Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
US20170290773A1 (en) Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
EP0937456A1 (fr) Dispersion liposomale d'érythropoietine
EP2157096B1 (fr) Molécule amphipathique, agrégat moléculaire comprenant la molécule amphipathique, et utilisation de l'agrégat moléculaire
KR20140026373A (ko) 염증 억제용 펩티드
WO2017213328A1 (fr) Liposome comprenant un conjugué récepteur synthétique-phospholipide, et composition pour le transfert d'un matériau fonctionnel qui peut se lier au récepteur synthétique et qui comprend, en tant que principe actif, un ligand auquel est lié le matériau fonctionnel
US7153490B2 (en) Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumors
KR20060123341A (ko) 친유성 아민 함유 약제를 포함하는 안정한 리포좀 조성물
EP0914827B1 (fr) Compositions medicamenteuses ophtalmiques
EP2543360A1 (fr) Bicelles encapsulées dans des liposomes et leur application dans des systèmes dilués
EP0588477B1 (fr) Composition médicinale contenant du TCF-II
KR101971451B1 (ko) ２―하이드록시올레산이 포함된 지질 비히클의 용도
EP4159210A1 (fr) Liposome contenant de l'acide éthylènediamine tétraacétique ou un sel de celui-ci et de l'éribuline ou un sel pharmaceutiquement acceptable de celle-ci
US20150174204A1 (en) Granulocyte-macrophage colony-stimulating factor for the treatment of bronchial asthma
US20160256528A1 (en) Compositions and methods for treating or preventing radiation- or chemotherapy-induced pulmonary dysfunction
US8809495B2 (en) Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
KR101846090B1 (ko) 독소루비신 함유 페길화된 리포좀 제제의 제조방법

Legal Events

Date Code Title Description
FZDE Discontinued